Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Induction with Cytosine Arabinoside/Daunomycin with or without Lithium Carbonate for Acute Myelogenous Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				over 15								SEG-A07


2.		Phase III L-PAM vs Hexa-CAP (HMM/CTX/ADR/CACP), with Crossover for Failures, for Resected, Stage III/IV Epithelial Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				70 and under								UCCRC-2627 NCI-D78-014-185

Last Modified: 7/12/2007


3.		Phase II Therapy with MER-BCG plus Lithium Carbonate and Mononuclear Cell Transfusion for Oligoleukemia and Preleukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				no age specified								MDA-DT-7908


4.		Phase II Chemotherapy with ADCONFU (ADR/CTX/VCR/5-FU) plus Lithium Carbonate for Nonresectable Solid Tumors in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				under 21				NCI				POG-7607B


5.		Phase II Supportive Therapy with Lithium Carbonate for Cancer Patients with Decreased Bone Marrow Reserve

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Closed				12 to 60								NCI-81-C-188


6.		Phase II Immunotherapy with Levamisole/Lithium Carbonate in Adults with Refractory CLL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								POA-27183 POA-27183


7.		Phase II Pilot Study of Induction with CAV (CTX/ADM/VCR) plus Lithium Carbonate Followed by Consolidation with VP-16 in Patients with Small Cell Cancer of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				no age specified								NCI-D82-048-0362


8.		Bone Marrow Restoration with Lithium Carbonate and MER-BCG for Oligoleukemia and Pre-Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Closed				no age specified								MDA-DT-8035P


9.		Chemotherapy with VP-16 plus Lithium Carbonate for Refractory Small Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Closed				no age specified								NCI-D80-062-102 DMS-7906


10.		Phase III Combination Chemotherapy with CACP/VBL/BLEO with and without Lithium Carbonate Neutropenia Attenuation for Advanced Germinal Cell Tumors in Male Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care, Treatment				Closed				under 60								NCOG-4T82

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute